Regnum

Regnum Financing Cash Flow

Net Financing Cash Flow of Regnum (RGMP) as of Oct 18, 2026.

Financing Cash Flow

0.00USD

Last updated:

Net Financing Cash Flow of Regnum is 2022 0.00 USD. Net Financing Cash Flow of Regnum was 2021 1.50 M USD. It decreases by % lower compared to the previous year.

The Regnum Financing Cash Flow history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Financing Cash Flow
Date
Financing Cash Flow
Jan 1, 2016
0.00 USD
Jan 1, 2017
10,000.00 USD
Jan 1, 2018
30,000.00 USD
Jan 1, 2019
0.00 USD
Jan 1, 2021
1.50 M USD
Jan 1, 2022
0.00 USD
The Regnum Financing Cash Flow history
YEARFinancing Cash FlowYoY
0.00USD-100.00%
1.50 MUSD—
0.00USD-100.00%
30,000.00USD+200.00%
10,000.00USD—
0.00USD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Regnum Stock analysis

What does Regnum do? Regnum Corp, headquartered in New York City, develops and commercializes therapeutics for rare and infectious diseases. The company's primary asset is the U.S. commercial rights to leronlimab (PRO 140), a monoclonal antibody targeting the CCR5 receptor to block R5 strains of HIV. Listed on 15 March 2019, Regnum focuses on entry inhibitor therapies that prevent HIV from entering healthy cells by binding to CCR5. Regnum is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Regnum stock

On Eulerpool you can find the complete historical development of Net Financing Cash Flow Regnum since 2006 – with annual values, charts, and detailed analysis.

Financing cash flow measures cash flows from debt issuance/repayment, equity transactions, and dividend payments.

Net Financing Cash Flow's USD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Net Financing Cash Flow's Regnum historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Cash Flow — Regnum

All Key Metrics — Regnum